Status:
RECRUITING
Golf Recreational Exercise for Enhanced Survivorship in Prostate Cancer Survivors
Lead Sponsor:
University of Southern California
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Localized Prostate Carcinoma
Locally Advanced Prostate Carcinoma
Eligibility:
MALE
55-85 years
Phase:
NA
Brief Summary
This clinical trial evaluates a golf recreational exercise program for enhancing survivorship in underrepresented prostate cancer survivors. Golf is a multimodal recreational activity that requires pa...
Detailed Description
PRIMARY OBJECTIVES: I. To recruit, screen, and enroll prostate cancer survivors. II. To examine the safety, feasibility, and adherence, of the 10-week (wk) GREENS program. III. To analyze the pre-po...
Eligibility Criteria
Inclusion
- First time, primary diagnosis of prostate cancer (PCa)
- Currently receiving androgen deprivation therapy (ADT) and/or androgen receptor blocker) for more than 6 months
- Older adult male: 55-85 years old
- The ability to stand independently without external support
- No or minimal golf experience (played \< 5 times in the past 10 years)
- English speaking
Exclusion
- Second cancer diagnosis (excluding non-invasive skin cancers) or bone metastases
- Prostatectomy less than 6 months prior to study enrollment (prostatectomy is not a requirement for study entry)
- Symptomatic cardiovascular disease, active angina, uncontrolled hypertension (systolic blood pressure (SBP) \> 160 or diastolic blood pressure (DBP) \> 90, high resting pulse heart rate (HR) \> 90), symptomatic orthostatic hypotension
- Unstable asthma, exacerbated chronic obstructive pulmonary disease (COPD\]
- History of injury or orthopedic operation within the last 6 months
- Movement disorders (e.g., Parkinson's disease (PD) or other neurological disorders), hemiparesis or paraparesis
- Severe vision or hearing problems
Key Trial Info
Start Date :
September 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2027
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT06500169
Start Date
September 1 2023
End Date
September 1 2027
Last Update
December 4 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Los Angeles General Medical Center
Los Angeles, California, United States, 90033
2
USC / Norris Comprehensive Cancer Center
Los Angeles, California, United States, 90033